In "The Real World Epidemiological Evidence Collaboration Agreement," Pfizer commits to provide Israel with vaccine to achieve herd immunity as soon as possible.
Announcing foreign currency purchases in advance has worked wonders but the forces strengthening the shekel remain the same.
Explaining the Bank of Israel's decision to buy $30 billion, Andrew Abir spoke of providing certainty and protecting jobs. Market sources: It's a game changer.
CFO Ronen Faier explains the strategy and culture that led SolarEdge to becoming the most valuable Israeli company on Wall Street.
Adelson's lavish support was a mainstay of the political success of both Donald Trump and Benjamin Netanyahu.
The neighborhoods ranked as top quality by Israel's Central Bureau of Statistics have surprisingly reasonable prices.
Experts are alarmed about possible breaches of confidentiality and the lack of transparency in Israel's vaccine deal with Pfizer.
ExoProTher Medical is using the body's own anti-cancer agent to treat brain cancer.
International bioethics expert Prof. Vardit Ravitsky weighs the pros and cons of a 'green passport' for those already vaccinated.
All eyes will be on Israel to see not only if the jabs work but also if the country can use its success to come smoothly out of lockdown.
Yoav Zeif took the helm of 3D printer company Stratasys just before Covid-19 broke out. He tells "Globes" how he used the crisis.
An oligarch with $160,000 cash, and a man smuggling $40,000 in fish are among those caught at the airport bringing unreported cash into Israel, the tax authority reports.
NovoCure's innovative cancer treatment has already made it the third most valuable Israeli company on Wall Street. CEO Asaf Danziger talks to "Globes".
Covid-19 dealt the conference and events platform developer a seemingly lethal blow but it pivoted swiftly to virtual conferences.